Skip to main content
Genome Medicine logoLink to Genome Medicine
. 2021 Jun 22;13:106. doi: 10.1186/s13073-021-00915-w

Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

Na Zhu 1,2,#, Emilia M Swietlik 3,#, Carrie L Welch 1,#, Michael W Pauciulo 4,5,#, Jacob J Hagen 1,2, Xueya Zhou 1,2, Yicheng Guo 2, Johannes Karten 6, Divya Pandya 3, Tobias Tilly 3, Katie A Lutz 4, Jennifer M Martin 3,7, Carmen M Treacy 3, Erika B Rosenzweig 1, Usha Krishnan 1, Anna W Coleman 4, Claudia Gonzaga-Jauregui 8, Allan Lawrie 9, Richard C Trembath 10, Martin R Wilkins 11; Regeneron Genetics Center8; PAH Biobank Enrolling Centers’ Investigators12; NIHR BioResource for Translational Research - Rare Diseases13; National Cohort Study of Idiopathic and Heritable PAH14, Nicholas W Morrell 3,7,15,16,#, Yufeng Shen 2,17,#, Stefan Gräf 3,18,7,#, William C Nichols 4,5,#, Wendy K Chung 1,19,20,✉,#
PMCID: PMC8220777  PMID: 34158098

Correction to: Genome Med 13, 80 (2021)

https://doi.org/10.1186/s13073-021-00891-1

It was highlighted that the original article [1] contained an error in the name of Claudia Gonzaga-Jauregui. It was incorrectly captured as Gonzaga-Juaregui. The original article has been updated.

Footnotes

Na Zhu, Emilia M. Swietlik, Carrie L. Welch, Michael W. Pauciulo contributed equally to this work.

Nicholas W. Morrell, Yufeng Shen, Stefan Gräf, William C. Nichols and Wendy K. Chung jointly supervised the work.

Reference

  • 1.Zhu N, et al. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH. Genome Med. 2021;13:80. doi: 10.1186/s13073-021-00891-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genome Medicine are provided here courtesy of BMC

RESOURCES